Intraabdominal and SSTI Flashcards
(134 cards)
1
Q
Peritonitis
A
K
2
Q
Inflammation of the peritoneum (serous membrane lining the abdominal
cavity)
A
O
3
Q
Types
A
L
4
Q
Primary
A
L
5
Q
Secondary
A
L
6
Q
Spontaneous or idiopathic, no primary focus of infection
A
O
7
Q
Occurs secondary to an abdominal process
A
O
8
Q
Causes of Secondary Peritonitis
A
O
9
Q
Peptic ulcer perforation
A
L
10
Q
Perforation of a GI organ
A
K
11
Q
Appendicitis
A
L
12
Q
Endometritis secondary to intrauterine
device
A
K
13
Q
Bile peritonitis
A
L
14
Q
Pancreatitis
A
P
15
Q
Operative contamination
A
P
16
Q
Diverticulitis
A
-
17
Q
Intestinal neoplasms
A
O
18
Q
GI normal flora
A
S
19
Q
Peritonitis: Microbiology
A
D
20
Q
Stomach and proximal small intestine:
A
O
21
Q
Aerobic and facultative gram-positive and gram-negative organisms
A
K
22
Q
Ileum
A
O
23
Q
E. coli, Enterococcus, anaerobes
A
O
24
Q
Large intestine:
A
L
25
Anaerobes (i.e., Bacteroides, Clostridium perfringens)
K
26
Aerobic and facultative gram-positive and gram-negative organisms (i.e., E. coli,
Streptococcus, Enterococcus, Klebsiella, Proteus, Enterobacter)
O
27
Peritonitis: Clinical presentation
L
28
Abdominal pain aggravated by motion, rebound tenderness
L
29
Bowel paralysis
L
30
Pain with breathing
L
31
Decreased renal perfusion
O
32
Ascitic fluid
K
33
Protein
K
34
WBCs
K
35
more than 3 g/dL
K
36
Therapy or prophylaxis should be limited in
K
37
Bowel injuries caused by trauma that are repaired within 12 hours (treat for less
than 24 hours)
K
38
Intraoperative contamination by enteric contents (treat for less than 24 hours)
L
39
Perforations of the stomach, duodenum, and proximal jejunum (unless patient is
on antacid therapy or has malignancy) (prophylactic antibiotics for less than 24
hours)
K
40
Acute appendicitis without evidence of perforation, abscess, or peritonitis (treat
for less than 24 hours)
,
41
Mild to moderate community-acquired infection
K
42
Cefoxitin
M
43
Cefazolin, cefuroxime, ceftriaxone, or cefotaxime plus metronidazole
L
44
Ertapenem
K
45
Moxifloxacin
L
46
Ciprofloxacin or levofloxacin plus metronidazole
L
47
Tigecycline
K
48
High-risk or severe* community-acquired or health
care–acquired infection
L
49
Piperacillin/tazobactam •
L
50
Comorbidities and organ dysfunction
51
Ceftazidime plus metronidazole or cefepime plus
,
52
Inability to achieve adequate source control
metronidazole
,k
53
Presence of malignancy
K
54
Imipenem/cilastatin or meropenem
K
55
Severe physiologic disturbance
I
56
Ciprofloxacin plus metronidazole or levofloxacin plus
metronidazole (not for health care–acquired infections)
K
57
Immunosuppression
K
58
High-risk or severe:
I
59
APACHE II score >15
I
60
Advanced age
J
61
Poor nutritional status/low albumin concentration
J
62
Comorbidities and organ dysfunction
K
63
Inability to achieve adequate source control
K
64
Presence of malignancy
J
65
Severe physiologic disturbance
J
66
Immunosuppression
K
67
Therapy duration:
K
68
4 days (when source control is complete)
J
69
Cellulitis
K
70
Acute spreading skin infection that involves primarily the deep
dermis and subcutaneous fat
J
71
Poorly defined margins
K
72
Warmth, pain, erythema and edema, and tender lymphadenopathy
J
73
Malaise, fever, and chills
J
74
Cellulitis: Microorganism
K
75
Mostly Streptococcus pyogenes and occasionally S. aureus (rarely
other organisms)
K
76
Blood cultures are rarely positive and not routinely recommended
unless severe systemic symptoms are present or if the patient is
immunosuppressed
N
77
Necrotizing Fasciitis
K
78
Significant systemic symptoms, including shock and organ failure
J
79
Necrotizing Fasciitis: Microbiology
N
80
Mixed infection with facultative and anaerobic bacteria (Type 1)
G
81
S. pyogenes (Type 2)
F
82
Clostridial myonecrosis (Type 3)
G
83
perianal abscess,
J
84
abdominal surgery
J
85
trauma
J
86
injection sites in persons who inject drugs
M
87
varicella
J
88
minor trauma (cuts, burns, and
splinters),
J
89
surgical procedures
J
90
Involves the skeletal muscle.
G
91
Gas production and muscle necrosis are prominent features of this infection, is
commonly referred to as gas gangrene.
G
92
Surgical debridement: Most important therapy and often repeated
debridement is necessary
V
93
Antibiotics are not curative; given in addition to surgery (if used early,
may be effective alone)
G
94
Non purulent cellulitis
Mild
Moderate
Sever
C
95
Purulent cellulitis
Mild
Moderate
Sever
Df
96
Oral antibiotic to cover streptococcus
Penicillin
Cephalexin
Dicloxacillin
Clindamycin
F
97
Oral antibiotic to cover both MRSA and streptococcus
TMP-SMXor doxycycline + pencillin or amoxicillin or cephalexin
C
98
Iv antibiotic to cover streptococcus
Pencillin
Cefazolin
Ceftrixone
Clindamycin
F
99
Iv antibiotic to cover both MRSA and streptococcus
Vancomycin
Daptomycin
Linezolid
Telvancin
Ceftaroline
F
100
Incision and drainage of abscess, antibiotic not required
D
101
Incision and drainage of abscess, no antibiotic
F
102
Incision and drainage , oral antibiotic to cover MRSA
TMP-SMX
Doxycycline
D
103
Vancomycin + Piperacillin tazobactam or imipenem /cilastatinor meropenem
V
104
Vancomycin or linezolid + Piperacillin tazobactam or impenem/ cilastain or meropenem or ertapenem or ceftrixone + metronidazole
M
105
Duration 5 days
F
106
K
107
Duration 1-2 week
F
108
Associated with penetrating trauma
D
109
Purpulent drainage
C
110
Nasal continuation with MRSA
D
111
Concurrent evidence of MRSA infection elsewhere
Cd
112
Systemic inflammatory response syndrome ( SIRS ) criteria
K
113
Primary peritonitis in patient with cirrhosis non sever infection
N
114
Primary peritonitis in patient with cirrhosis sever infection
L
115
Perforated peptic ulcer
D
116
Cholangitis
D
117
Ceftrixone, cefotaxime
,
118
E.coli, klebsilla, penumococcci
C
119
Piperacillin /tazobactam , carbapenm
S
120
Aztreonam + vancomycin
D
121
Aztreonam + levofloxacin
D
122
Aztreonam + moxifloxacin
D
123
Ceftrixone or cefotaxime with or without metronidazole
D
124
Streptococcus, E.coli
D
125
E.coli, klebsiella , proteus
D
126
First generation cephalosporin
D
127
What is Normal floral of skin
K
128
Coagulase negative staphylococcus
D
129
Micrococci
D
130
Corynebacterium
D
131
Propiobacterium
D
132
Acinetbacter
D
133
Non pharmacology for cellulitis
L
134
What is the role of clindamycin in necrotizing soft tissue infection
D
